CadheRx Therapeutics is Drug Discovery in United States that focus on resistant epithelial cancers business. Founded in 2014. They cover business area such as developer, therapeutic antibody, solid tumor, particularly Cetuximab, Herceptin, resistant epithelial cancer, patient, surgery.
2014
( 10 years old in 2024 )
Resistant Epithelial Cancers
-
11099 North Torrey Pines Road
Suite 290
San Diego, CA 92037
United States
Private
developertherapeutic antibodysolid tumorparticularly CetuximabHerceptinresistant epithelial cancerpatientsurgery
* We use standard office opening hours in near CadheRx Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CadheRx Therapeutics is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), CadheRx Therapeutics business is focusing on Resistant Epithelial Cancers.
CadheRx Therapeutics headquarter office and corporate office address is located in 11099 North Torrey Pines Road Suite 290 San Diego, CA 92037 United States.
CadheRx Therapeutics was founded in United States.
In 2024, CadheRx Therapeutics is currently focus on resistant epithelial cancers sector.
Above is snippet of Google Trends for "resistant epithelial cancers" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CadheRx Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
